SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-088964
Filing Date
2021-07-02
Accepted
2021-07-02 17:01:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2121220d2_424b5.htm 424B5 5318
2 GRAPHIC image_003.jpg GRAPHIC 5326
  Complete submission text file 0001104659-21-088964.txt   13998
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-230604 | Film No.: 211071150
SIC: 2836 Biological Products, (No Diagnostic Substances)